Pharmacological targeting of the IL-17/neutrophil axis attenuates calcific deposits in rat models of calciphylaxis

By afschroeder • October 2, 2025

Tao B, Cao EZ, Hyun J, Ramadoss S, Alvarez JF, Su L, Sun Q, Liu Z, Zhang L, Espinoza A, Gu Y, Ma F, Li S, Pellegrini M, Deb A. Pharmacological targeting of the IL-17/neutrophil axis attenuates calcific deposits in rat models of calciphylaxis. J Clin Invest. 2025 Aug 15;135(19):e190369. doi: 10.1172/JCI190369. PMID: 41031886; PMCID: PMC12483568.

Tags: Bone disease, Cardiology/Epi, cell biology, dermatology, Neutrophils, Post Doc, Publications, skin

Exploring cardiac-related PTSD symptoms in patients with implantable cardioverter defibrillators: protocol for an open-label trial of written exposure therapy and qualitative study

Meinhausen C, Ajijola OA, Sumner JA. Exploring cardiac-related PTSD symptoms in patients with implantable cardioverter defibrillators: protocol for an open-label trial of written exposure therapy[...]

Ferumoxytol-Enhanced Cardiovascular Magnetic Resonance Imaging: Applications and Technical Advances

Nguyen KL, Loke YH, Li JM, Bedayat A, Yang HJ, Xie Y, Christodoulou AG, Li D, Zhong X, Finn JP. Ferumoxytol-Enhanced Cardiovascular Magnetic Resonance Imaging:[...]

Breaking the Chain of Survival: What Progetto Vita Tells Us, and What It Doesn’t

Talishinsky A, Ajijola OA, Salhi RA. Breaking the Chain of Survival: What Progetto Vita Tells Us, and What It Doesn't. J Am Heart Assoc. 2025[...]